Clinical Trial Update: Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE Studies

View source ↗

Summary

This is a clinical trial update describing a follow-up study of patients who experienced thromboembolic events in the ENABLE studies for Hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Novartis | Conditions: Hepatitis C | Status: COMPLETED